Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2009
11/19/2009WO2009140124A1 Anti-cxcr4 antibodies
11/19/2009WO2009139930A2 Antibodies and processes for preparing the same
11/19/2009WO2009139891A2 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
11/19/2009WO2009139822A1 Anti-hepcidin antibodies and methods of use
11/19/2009WO2009139624A1 Process for producing milk fractions rich in secretory immunoglobulins
11/19/2009WO2009138850A1 Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3
11/19/2009WO2009138714A1 Purification process for antibody fragments using derivatized triazines as affinity ligands
11/19/2009WO2009138519A1 AMINO ACID SEQUENCES DIRECTED AGAINST CXCR4 AND OTHER GPCRs AND COMPOUNDS COMPRISING THE SAME
11/19/2009WO2009138494A2 Amino acid sequences directed against toll-like receptors and polypeptides comprising the same for the treatment of diseases related to toll-like receptors
11/19/2009WO2009138484A2 Antibody purification process
11/19/2009WO2009138473A2 Intracellular antibody delivery
11/19/2009WO2009138413A1 Single domain antibodies that bind il-13
11/19/2009WO2009138236A1 Novel and powerful mhc-class ii petptides derived from survivin
11/19/2009WO2009091826A3 Compositions and methods related to a human cd19-specific chimeric antigen receptor (h-car)
11/19/2009WO2009086398A3 Anti-t. cruzi antibodies and methods of use
11/19/2009WO2009059235A3 Immunoglobulin display vectors
11/19/2009WO2008131940A3 Combination of immunological agent and sensitizing agent for the treatment of cancer
11/19/2009WO2008119567A8 Cross-species-specific cd3-epsilon binding domain
11/19/2009US20090288180 Novel protein and production process and use thereof
11/19/2009US20090288176 Novel Gene Disruptions, Compositions and Methods Relating Thereto
11/19/2009US20090286962 Chimeric antibodies with part new world primate binding regions
11/19/2009US20090286958 Interferon-beta fusion proteins and uses
11/19/2009US20090286954 Human cDNA Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their Use
11/19/2009US20090286854 Aptamers directed to muci
11/19/2009US20090286737 Erbb interface peptidomimetics and methods of use thereof
11/19/2009US20090286721 Targeted plasminogen activator fusion proteins as thromobolytic agents
11/19/2009US20090286714 Novel molecules of the card-related protein family and uses thereof
11/19/2009US20090286329 Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
11/19/2009US20090286316 Nucleic acid and corresponding protein entitled 158P3D2 useful in treatment and detection of cancer
11/19/2009US20090286313 Non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
11/19/2009US20090286312 Methods and Compositions for Treating Allergic Diseases
11/19/2009US20090286283 Method and affinity column for purifying proteins
11/19/2009US20090286282 Method for Producing Antibody Fragments
11/19/2009US20090286265 Cripto Blocking Antibodies And Uses Thereof
11/19/2009US20090286263 Skin tape stripping: a non-invasive diagnostic strategy for dermal exposure to cytotoxic compounds
11/19/2009US20090286256 Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides
11/19/2009US20090286252 Nrif3, novel co-activator for nuclear hormone receptors
11/19/2009US20090286246 Methods for Identifying Compounds that Affect Expression of Cancer-Related Protein Isoforms
11/19/2009US20090286230 Methods, Devices, Kits and Compositions for Detecting Roundworm
11/19/2009US20090286229 Methods, Devices, Kits and Compositions for Detecting Roundworm
11/19/2009US20090286228 Methods, Devices, Kits and Compositions for Detecting Roundworm
11/19/2009US20090286227 Methods, Devices, Kits and Compositions for Detecting Whipworm
11/19/2009US20090286224 Method for producing human antibodies with properties of agonist, antagonist, or inverse agonist
11/19/2009US20090285859 Allergenic proteins of natural rubber latex, their production and use in assays
11/19/2009US20090285853 Nucleic Acids Encoding Respiratory Syncytial Virus Subgroup B strain 9320
11/19/2009US20090285843 Epitope sequences
11/19/2009US20090285839 Antigen uptake receptor for candida albicans on dendritic cells
11/19/2009US20090285837 Her2 antibody composition
11/19/2009US20090285835 Antibodies which bind human CXCR3
11/19/2009US20090285831 Immunointeractive molecules
11/19/2009US20090285830 Antibodies to lymphotoxin-alpha
11/19/2009US20090285829 Medicinal Agent and Method for Curing Prostate Diseases
11/19/2009US20090285828 Anti-PECAM Therapy for Metastasis Suppression
11/19/2009US20090285825 Novel snake toxin
11/19/2009US20090285824 immunoglobulins; humanizing; chimera; fragments; complementary determining regions; breast cancer
11/19/2009US20090285822 Prevention and treatment of amyloidogenic disease
11/19/2009US20090285821 Campylobacter Pilus Protein, Compositions and Methods
11/19/2009US20090285820 Methods of Treating Degenerative Disorders With Rac 1B Inhibitor
11/19/2009US20090285819 Methods and compositions for treating influenza
11/19/2009US20090285818 Cripto Blocking Antibodies and Uses Thereof
11/19/2009US20090285817 Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene
11/19/2009US20090285816 Albumin Fusion Proteins
11/19/2009US20090285814 CD 40 Binding Molecules and CTL Pepetides for Treating Tumors
11/19/2009US20090285813 Antibodies and methods for making and using them
11/19/2009US20090285812 human P-selectin glycoprotein ligand 1 (PSGL-1) monoclonal antibodies which block both selectin and chemokine binding to PSGL-1 expressed on leukocytes, lymphocytes and endothelial cells; inflammation such as inflammatory bowel disease
11/19/2009US20090285810 Humanized anti-tgf-beta antibodies
11/19/2009US20090285809 Prevention and treatment of amyloidogenic diseases
11/19/2009US20090285807 Anti-Met Monoclonal Antibody, Fragments and Vectors Thereof, for the Treatment of Tumors and Corresponding Products
11/19/2009US20090285806 Methods and compositions for improving recombinant protein production
11/19/2009US20090285805 Binding molecules
11/19/2009US20090285804 Anti-ADDLs antibodies and uses thereof
11/19/2009US20090285803 ANTI-PirB ANTIBODIES
11/19/2009US20090285802 Highly concentrated stabilized igm solution
11/19/2009US20090285801 Calcium-Sensing Receptor 2 (CaR2) and Methods for Using
11/19/2009US20090285799 Antibody Antagonists of Interleukin-13 Receptor Alpha1
11/19/2009US20090285796 Mutant jak3 kinase in human leukemia
11/19/2009US20090285781 Medicament and a method of treating a pathological syndrome
11/19/2009US20090285777 Uses of Mammalian Cytokine; Related Reagents
11/19/2009US20090285753 Novel haptotactic peptides
11/19/2009US20090285751 Cancerous disease modifying antibodies
11/19/2009CA2760493A1 Staphylococcus aureus-specific antibody preparations
11/19/2009CA2724630A1 Targeted coagulation factors and method of using the same
11/19/2009CA2724525A1 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
11/19/2009CA2724444A1 Process for producing milk fractions rich in secretory immunoglobulins
11/19/2009CA2724415A1 Anti-psgl-1 antibodies and methods of identification and use
11/19/2009CA2724409A1 Anti-cxcr4 antibodies
11/19/2009CA2724279A1 Anti-il-6/il-6r antibodies and methods of use thereof
11/19/2009CA2724231A1 Novel targets for regulation of angiogenesis
11/19/2009CA2724208A1 Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same
11/19/2009CA2724198A1 Novel and powerful mhc-class ii petptides derived from survivin
11/19/2009CA2724019A1 Purification process for antibody fragments using derivatized triazines as affinity ligands
11/19/2009CA2723973A1 Anti-fn14 antibodies and uses thereof
11/19/2009CA2723430A1 Anti-pirb antibodies
11/19/2009CA2723114A1 Antibodies and processes for preparing the same
11/19/2009CA2722968A1 Hematopoietic cells expressing the protein susd3 and ligands for the protein susd3
11/19/2009CA2722600A1 Anti-hepcidin antibodies and methods of use
11/18/2009EP2119785A1 Novel peptides
11/18/2009EP2119780A1 Genetically recombinant antibody composition having enhanced effector activity
11/18/2009EP2119778A1 Method for activation of helper t cell and composition for use in the method
11/18/2009EP2119777A1 Gaba neuron progenitor cell marker 65b13
1 ... 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 ... 1494